Enabling you to identify and mitigate the intrinsic risk in your operations, supply chains and business processes.
Evaluating how your products and services meet and exceed quality, safety, sustainability and performance standards.
Validating the specifications, value and safety of your raw materials, products and assets.
Our inhalation drug development experts to exhibit at Respiratory Drug Delivery Europe (RDD) 2017 Conference, Nice (Antibes), France, April 25-28, 2017
Respiratory drug delivery development can be a challenging process yet there is a clear need to develop more effective orally inhaled and nasal drug products (OINDPs) to treat lung infection and lung disease. The lung can also present an effective delivery route to the rest of the body, potentially achieving a faster therapeutic effect and reducing the side effects that can be associated with other drug delivery routes.
During the forthcoming conference, Intertek's inhalation experts will be present to discuss aerosol drug delivery development topics including strategic approaches to OINDP development and novel in vitro testing methods such as the use of MDRS data as part of a weight-of-evidence approach in lieu of a traditional clinical endpoint study for generic nasal suspensions.
Our team will also provide updates on the latest developments of our inhaled product development capabilities which includes for both small molecules and biologics.
Our integrated formulation and analytical teams carry out early stage pre-formulation support, solubility screening, drug-excipient compatibility, stability testing and device selection support to aid clients working to develop formulations targeting specific regions of the respiratory tract or nasal cavity. Comprehensive protein characterisation services services, aligned to monitoring a protein’s structure and potency throughout formulation and storage, can also be provided.
Learn More About RDD
RDD Europe 2017 offers attendees the unique opportunity to participate in one of the largest and most focussed international conference of its kind, featuring in-depth presentations and discussion of pioneering respiratory drug delivery science in tandem with expanded opportunities for networking. Expert speakers will cover topics including new therapeutic opportunities and drug delivery technologies, novel in vitro and clinical testing methods, and new regulatory insight.
Venue: Palais des Congres d'Antibes, Nice (Antibes), France
Date: April 25-28, 2017
Need help or have a question?